ORLANDO, Fla. — A long-standing drug for heart failure might find new utility as a treatment for prostate cancer, a new study finds.
Digitalis, also called digoxin, is derived from the foxglove plant and has a lengthy medical history. Its role as a treatment for heart failure and heart arrhythmia has declined in recent years with the advent of newer drugs, but it remains an option for patients.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.